Oregon Health and Science University
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Oregon Health and Science University sits in the top decile of US sponsors by registered trial count (#67 of 15,742 sponsors by registered trial count).
Oregon Health and Science University: 546 sponsored US clinical trials, 91 recruiting.
Oregon Health and Science University sponsors 546 registered US clinical trials on ClinicalTrials.gov, 91 of them currently recruiting, and 370 completed. 73 of these trials are in Phase 3-4 (later-stage) and 92 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 6 trials.
Top-decile sponsor footprint
Oregon Health and Science University ranks in the top decile of sponsors by registered trial count (#67 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
370 of 420 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
546 total, page 5 of 11
Pharmacists Expand Access to Reproductive heaLthcare
NCT03830567
Characterizing Biomarkers of Early Parkinson's Disease Progression (TREG)
NCT03716258
Sleep and Circadian Mechanisms of Non-dipping Blood Pressure
NCT03558893
Ataxia in Essential Tremor: Describing the Differences Between Disease Process and Treatment Effect
NCT03769961
Cannabinoids for Pain Control During Medical Abortion
NCT03604341
SpHincterotomy for Acute Recurrent Pancreatitis
NCT03609944
MitoQ for Fatigue in Multiple Sclerosis
NCT03166800
Capillary Refill for Assessment of Dehydration
NCT03670394
Characterizing the Impact and Treatment of Reproductive Tract Bleeding on Women and Post-menarchal Girls With Bleeding Disorders
NCT03834727
Tetrahydrocannabinol (THC) and Sleep
NCT03560934
Objective Dual-task Turning Measures for Return-to-duty Assessments
NCT03892291
Neurosciences-Intensive Care Unit Electrical Stimulation
NCT03547687
Radial Artery Vasodilation Heat Study
NCT03620383
Improving Walking Automaticity in Parkinson's Disease: Levodopa or Donepezil
NCT03599726
Evaluation of Physician-based Decision Support
NCT03443713
A Community-based Assessment of Skin Care, Allergies, and Eczema
NCT03409367
Can Early Initiation of Rehabilitation With Wearable Sensor Technology Improve Outcomes in mTBI?
NCT03479541
Ixekizumab in the Treatment of Pityriasis Rubra Pilaris (PRP)
NCT03485976
Subarachnoid Hemorrhage and Soluble Epoxide Hydrolase Inhibition Trial
NCT03318783
Micronutrients for Attention-Deficit Hyperactivity Disorder in Youth (MADDY) Study
NCT03252522
Single Hormone Closed Loop Study With PDT Sensor
NCT03528174
Stress Hormones and IUDs
NCT03499379
Evaluating Control of Hypertension - Effect of Social Determinants
NCT03545763
Three Way Crossover Closed Loop Study With Xeris Glucagon
NCT03424044
Cohort Study of Risk Factors for Postoperative Cognitive Decline
NCT03676738
Post-Op Lidocaine Patch
NCT03500211
Vitamin C to Reduce Morning Cardiovascular Risk
NCT03290612
Comparing Treatments for HIV-Infected Opioid Users in an Integrated Care Effectiveness Study (CHOICES) Scale-Up
NCT03275350
Estrogen and the Urogenital Microbiome in GSM
NCT03336437
Comparing Subcutaneous Testosterone to Intramuscular Testosterone in Gender Affirming Care of Transgender Male Adolescents
NCT03864913
Electrical Stimulation to Promote Recovery in Bells Palsy
NCT03836989
How DHEA Supplements Affect Coagulation in Women Using Birth Control Pills
NCT03418363
Parent Mentor Interventions for Early Childhood Obesity
NCT03330743
Feasibility And Safety Of Transjugular Intrahepatic Portosystemic Shunt (TIPS) Creation Using A Radiofrequency Guidewire
NCT03451149
Rapid MRI for Acute Pediatric Head Trauma
NCT03291964
Oregon Military Employee Sleep and Health Study
NCT02946736
Effectiveness of Orally Dosed Emergency Contraception in Obese Women - LNG
NCT02863445
Treating Postmenopausal Dyspareunia Where it Hurts
NCT03240081
Vitamin C Supplementation to Pregnant Smokers: Follow-up of 2 Randomized Trials Plus Changes in DNA Methylation
NCT03206710
Effectiveness of Orally Dosed Emergency Contraception in Obese Women - UPA
NCT02859337
Hepatitis C Treatment in PWIDs: MAT or Syringe Exchange Assisted-therapy vs Standard of Care
NCT03093415
Sharing History Through Active Reminiscence and Photo-imagery - With MCI
NCT05906667
Randomized Trial of Early Hemodynamic Management of Patients Following Acute Spinal Cord Injury
NCT02878850
Exercise Physiology Study
NCT03090451
Tech4Rest Trial With Team Truck Drivers
NCT03108599
Opioid Analgesia for MAB
NCT03139240
VCSIP Follow-up Study
NCT03203603
Evaluation of a Web-Based Fall Prevention Program on People With Multiple Sclerosis
NCT02885233
The Effect of Sugammadex Versus Neostigmine on Postoperative Pulmonary Complications
NCT02861131
Treatment of Unfavorable Bleeding Patterns in Contraceptive Implant Users
NCT02903121
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 52 |
| Phase 2 | 40 |
| Phase 3 | 6 |
| Phase 4 | 67 |
Therapeutic Areas
What is open in the Oregon Health and Science University pipeline
91 recruiting of 546 indexed (17% open); 370 completed (68%).
Phase mix: 73 late (III/IV) vs 92 early (I/II) (balanced across stages).
Top condition: Obesity (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Oregon Health and Science University: open-pipeline peers nationwide
Peers matched on 546 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
Oregon Health and Science University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 546 trials (± recruiting share)
- Ohio State University · 552 trials · 21% recruiting
- Amgen · 558 trials · 10% recruiting
- Merck Sharp & Dohme · 558 trials · 22% recruiting
- Virginia Commonwealth University · 558 trials · 14% recruiting
Sponsors near 17% open enrollment (± trial volume)
- Adagene · 17% recruiting · 6 trials
- Agendia · 17% recruiting · 6 trials
- Akamis Bio · 17% recruiting · 6 trials
- Angiodynamics · 17% recruiting · 12 trials
Related
What to do with this Oregon Health and Science University page
546 registered trials is a research-attention snapshot, not an endorsement of Oregon Health and Science University or any single study.
- 91 of Oregon Health and Science University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Oregon Health and Science University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Oregon Health and Science University pipeline card: 546 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.